arrow
M

Mark V. Mishra

nih national cancer institute (nci)
H指数:31
被引数:3,421

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A pilot study of laser interstitial thermal therapy (LITT) followed by hypofractionated radiation therapy (hypoRT) for patients with recurrent gliomas

一项关于激光间质热疗(LITT)后序贯低分割放射治疗(hypoRT)用于复发性胶质瘤患者的初步研究

2025-11-010
OAAI
Phase III Randomized Trial of Proton vs. Photon Therapy for Patients with Non-metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (Radcomp) Consortium Trial: Health-Related Quality of Life Outcomes

III期随机试验:比较质子与光子疗法在行全面淋巴结放疗的非转移性乳腺癌患者中的效果——一项放射治疗比较有效性(Radcomp)联盟试验:健康相关生活质量结局

2025-10-140
PRE
Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation Therapy

转移灶定向治疗的基因组预测因子:含或不含雄激素剥夺治疗

2025-09-200
PREAI
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer
2025-03-011
PRE
Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected Meningiomas

使用(68)Ga-DOTATATE PET/CT进行切除后脑膜瘤的共识放射治疗计划制定指南

2024-12-011
PRE
A PIVOTAL, MULTICENTER TRIAL OF FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR PLASMA-BASED LIQUID BIOPSY IN PATIENTS WITH GLIOBLASTOMA (LIBERATE)

聚焦超声用于胶质母细胞瘤患者基于血浆的液体活检的血脑屏障破坏的关键多中心试验 (LIBERATE)

2024-11-110
PRE
A PROSPECTIVE, MULTICENTER TRIAL OF FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR LIQUID BIOPSY IN GLIOBLASTOMA (LIBERATE)
2024-10-170
PRE
Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial
2024-09-012
OAAI
Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology ' s RTOG 0614
2024-07-011
PRE
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial

根据竞争事件风险,雄激素剥夺治疗对前列腺癌预后的影响: 一项3期随机试验的二次分析

2024-04-013
PRE